The Journal of Nuclear Medicine and Molecular Imaging (JNMMI) is a peer-reviewed academic journal dedicated to advancing global research and collaboration in nuclear medicine and molecular imaging. Launched in August 2025, this quarterly publication (64 pages/issue) serves as a platform for scholars, clinicians, and industry professionals to share cutting-edge discoveries and innovations. 

Scope and Topics

JNMMI welcomes high-quality submissions, including original research articles, reviews, interesting cases, technical notes, guidelines, and consensus covering: 

- Clinical applications and translational research in nuclear medicine. 

- Basic research in radiopharmaceuticals and molecular imaging 

- Development and preclinical/clinical validation of novel molecular probes 

- Advances in nuclear imaging technology and equipment, along with their clinical significance 

Mission 

By fostering interdisciplinary dialogue, JNMMI aims to accelerate the translation of scientific breakthroughs into clinical practice, ultimately improving patient care in oncology, cardiology, neurology, and beyond. 

We cordially invite researchers worldwide to contribute your impactful work.